Drugs Affecting Blood and Blood Formation — MCQs

Drugs Affecting Blood and Blood Formation Indian Medical PG Practice Questions and MCQs

Question 101: Heparin is contraindicated in patients suffering from which of the following conditions?

A. Bleeding due to defibrination syndrome (Correct Answer)
B. Pulmonary tuberculosis
C. Subacute bacterial endocarditis
D. Large malignant tumours

Explanation: ### Explanation **Correct Answer: A. Bleeding due to defibrination syndrome** **Mechanism and Rationale:** Defibrination syndrome (often associated with Disseminated Intravascular Coagulation - DIC) is characterized by the systemic activation of coagulation, leading to the consumption of clotting factors and platelets. While Heparin is sometimes used in the *early* pro-thrombotic phase of DIC to stop the consumption of factors, it is **strictly contraindicated** once the patient enters the **hemorrhagic phase** (bleeding due to defibrination). Administering an anticoagulant like Heparin when the patient is already bleeding due to a lack of fibrinogen and clotting factors would exacerbate the hemorrhage, potentially leading to fatal outcomes. **Analysis of Incorrect Options:** * **B. Pulmonary Tuberculosis:** While severe hemoptysis is a relative caution, TB itself is not an absolute contraindication for heparin if a patient develops a VTE. * **C. Subacute Bacterial Endocarditis (SBE):** While there is a risk of septic emboli and mycotic aneurysms, SBE is generally considered a **relative contraindication**. Heparin is avoided unless there is a compelling reason (like a prosthetic valve), but it is not the "most" contraindicated compared to active defibrination bleeding. * **D. Large Malignant Tumours:** Malignancy is actually a highly **pro-thrombotic state** (Trousseau’s syndrome). Low Molecular Weight Heparin (LMWH) is often the treatment of choice for VTE in cancer patients. **NEET-PG High-Yield Pearls:** * **Absolute Contraindications for Heparin:** Active bleeding, bleeding disorders (Hemophilia), severe hypertension, recent surgery (brain, spinal cord, or eye), and **Heparin-Induced Thrombocytopenia (HIT)**. * **Antidote:** Protamine Sulfate (1 mg neutralizes 100 units of Heparin). * **Monitoring:** Unfractionated Heparin (UFH) is monitored using **aPTT** (Target: 1.5–2.5 times control). LMWH does not require routine monitoring. * **Drug of Choice in Pregnancy:** Heparin/LMWH (does not cross the placenta).

Question 102: What is true about fresh frozen plasma?

A. Used for treatment of antithrombin-3 deficiency
B. Used for treatment of Vitamin-K deficiency
C. Used for replacing factor VIII & IX, if deficiency
D. Best alternative for platelet transfusion (Correct Answer)

Explanation: ### Explanation Fresh Frozen Plasma (FFP) is a blood product obtained from whole blood by centrifugation and freezing within 8 hours of collection. It contains all coagulation factors, fibrinogen, and plasma proteins. **Why Option D is the Correct Answer:** While FFP is not a primary treatment for thrombocytopenia, it is considered the **best alternative for platelet transfusion** in specific clinical scenarios where specialized products are unavailable or when treating **Thrombotic Thrombocytopenic Purpura (TTP)**. In TTP, FFP provides the missing ADAMTS13 enzyme, making it a life-saving intervention. In the context of massive hemorrhage protocols, FFP is used alongside platelets to maintain hemostasis. **Analysis of Incorrect Options:** * **Option A:** While FFP contains Antithrombin III, it is not the treatment of choice. **Antithrombin III concentrates** or purified products are preferred to avoid volume overload. * **Option B:** Vitamin K deficiency is primarily treated with **Vitamin K (Phytomenadione)**. If immediate reversal is needed (e.g., life-threatening bleed), **Prothrombin Complex Concentrate (PCC)** is the gold standard, as it works faster and has a lower volume than FFP. * **Option C:** FFP contains Factors VIII and IX, but it is **not** the preferred treatment. **Specific factor concentrates** or **Cryoprecipitate** (for Factor VIII) are used to prevent fluid overload and ensure precise dosing. **High-Yield NEET-PG Pearls:** * **Storage:** FFP is stored at **-18°C or colder** and has a shelf life of **1 year**. * **Dosage:** The standard dose is **10–15 mL/kg**. * **Indication:** Most common use is the correction of multiple coagulation factor deficiencies (e.g., liver disease, DIC, or massive transfusion). * **Contraindication:** FFP should **never** be used simply for volume expansion or nutritional support (albumin).

Question 103: What is the mechanism of action of Rivaroxaban?

A. Direct factor Xa inhibitor (Correct Answer)
B. Activated factor VIIa
C. Vitamin K antagonist
D. None of the above

Explanation: **Explanation:** **1. Mechanism of the Correct Answer (Option A):** Rivaroxaban is a **Direct Oral Anticoagulant (DOAC)** that acts as a potent, highly selective, and **direct inhibitor of Factor Xa**. Factor Xa is the "nexus" of the coagulation cascade where the intrinsic and extrinsic pathways converge to form the common pathway. By binding directly to the active site of both free and clot-bound Factor Xa, Rivaroxaban prevents the conversion of prothrombin (Factor II) to thrombin (Factor IIa), thereby inhibiting fibrin clot formation. **2. Analysis of Incorrect Options:** * **Option B (Activated factor VIIa):** This is a pro-coagulant (e.g., Eptacog alfa) used to treat bleeding episodes in patients with hemophilia or Factor VII deficiency. It promotes clotting rather than inhibiting it. * **Option C (Vitamin K antagonist):** This describes the mechanism of **Warfarin**. Warfarin acts by inhibiting the enzyme Vitamin K Epoxide Reductase (VKOR), preventing the γ-carboxylation of Factors II, VII, IX, and X. Unlike Rivaroxaban, Warfarin has a slow onset and requires INR monitoring. **3. High-Yield NEET-PG Clinical Pearls:** * **The "-xaban" Suffix:** Remember that drugs with **"xa"** in their name (Rivaroxaban, Apixaban, Edoxaban) target Factor **Xa**. * **Advantages:** Unlike Warfarin, Rivaroxaban has a rapid onset, predictable pharmacokinetics (no routine monitoring required), and fewer drug-food interactions. * **Reversal Agent:** The specific antidote for Rivaroxaban and Apixaban is **Andexanet alfa**. * **Clinical Use:** It is a first-line choice for stroke prevention in non-valvular atrial fibrillation and the treatment/prophylaxis of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).

Question 104: Heparin inhibits the active form of the following coagulation factors except:

A. Factor V (Correct Answer)
B. Factor X
C. Factor XI
D. Factor XII

Explanation: The mechanism of action of **Unfractionated Heparin (UFH)** depends on its binding to **Antithrombin III (AT-III)** [2]. This binding induces a conformational change in AT-III, converting it from a slow to a rapid inhibitor of serine protease coagulation factors [3]. 1. **Why Factor V is the correct answer:** Heparin (via AT-III) specifically targets **serine proteases**. Coagulation factors are categorized into serine proteases (II, VII, IX, X, XI, XII) and **cofactors (V and VIII)** [4]. Since Factor V is a cofactor and not a protease, it is not directly inhibited by the Heparin-AT-III complex [4]. 2. **Why the other options are incorrect:** * **Factor X (Option B):** Heparin significantly accelerates the inhibition of Factor Xa [2]. Low Molecular Weight Heparin (LMWH) acts almost exclusively on Factor Xa [1]. * **Factor XI and XII (Options C & D):** These are part of the intrinsic pathway and are serine proteases. Heparin inhibits the active forms of factors XIIa, XIa, IXa, and IIa (Thrombin) [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** The efficacy of UFH is monitored using **aPTT** (intrinsic pathway), whereas LMWH does not require routine monitoring (but can be checked via Anti-Xa levels). * **Antidote:** **Protamine sulfate** is the specific antidote for heparin overdose (1 mg neutralizes ~100 units of heparin) [1]. * **Side Effects:** The most unique side effect is **Heparin-Induced Thrombocytopenia (HIT)**, caused by IgG antibodies against the Heparin-Platelet Factor 4 (PF4) complex [1]. * **Safe in Pregnancy:** Heparin does not cross the placenta, making it the anticoagulant of choice during pregnancy.

Question 105: Excessive bleeding due to heparin overdose is controlled by which of the following?

A. Protamine sulfate (Correct Answer)
B. Vitamin K
C. Factor VIII
D. Epsilon-aminocaproic acid

Explanation: **Explanation:** **Protamine sulfate** is the specific antidote for heparin overdose. It is a strongly basic (cationic) protein derived from salmon sperm. Heparin is a highly acidic (anionic) molecule; when administered, protamine sulfate binds ionically to heparin to form a stable, inactive salt complex. This process is known as **chemical antagonism**. It is important to note that 1 mg of protamine neutralizes approximately 100 units of heparin. **Why other options are incorrect:** * **Vitamin K:** This is the antidote for **Warfarin** (oral anticoagulant) toxicity, as it helps synthesize Vitamin K-dependent clotting factors (II, VII, IX, X). It has no effect on heparin. * **Factor VIII:** This is used in the management of **Hemophilia A** and von Willebrand disease, not for reversing drug-induced anticoagulation. * **Epsilon-aminocaproic acid (EACA):** This is an antifibrinolytic agent used to treat bleeding caused by **fibrinolytic/thrombolytic drugs** (like Streptokinase or Alteplase) by inhibiting plasminogen activation. **High-Yield Clinical Pearls for NEET-PG:** 1. **Protamine Dosage:** Excessive doses of protamine should be avoided because protamine itself has weak anticoagulant properties (it inhibits platelets and clotting factors). 2. **Monitoring:** The efficacy of heparin is monitored by **aPTT**, while the reversal by protamine is also reflected in the normalization of aPTT. 3. **Adverse Effects:** Rapid IV injection of protamine can cause histamine release leading to hypotension, bradycardia, and pulmonary hypertension. 4. **LMWH Reversal:** Protamine only partially reverses the effects of Low Molecular Weight Heparin (LMWH) and has no effect on Fondaparinux.

Question 106: Which of the following statements about oral anticoagulants is FALSE?

A. They act in vivo.
B. They act both in vivo and in vitro. (Correct Answer)
C. They interfere with the synthesis of Vitamin K.
D. They can cause hematuria.

Explanation: ### Explanation **1. Why Option B is the Correct (False) Statement:** Oral anticoagulants (like Warfarin) act as **Vitamin K antagonists** [1]. They work by inhibiting the enzyme **Vitamin K Epoxide Reductase (VKOR)**, which is essential for the gamma-carboxylation (activation) of clotting factors II, VII, IX, and X in the liver [3]. Because this process requires a functioning liver and cellular machinery to synthesize proteins, these drugs **only act *in vivo*** (inside a living body). They have no effect on blood already collected in a test tube (*in vitro*). In contrast, Heparin acts both *in vivo* and *in vitro* because it directly activates Antithrombin III in the plasma. **2. Analysis of Other Options:** * **Option A (They act *in vivo*):** This is a true statement. Their mechanism depends on the biological synthesis of clotting factors [1]. * **Option C (They interfere with the synthesis of Vitamin K):** This is technically true in the context of the "Vitamin K Cycle." They prevent the regeneration of the active (reduced) form of Vitamin K, effectively creating a functional deficiency that halts the synthesis of active clotting factors [3]. * **Option D (They can cause hematuria):** This is a true statement. Bleeding is the most common adverse effect of anticoagulants [2]. Hematuria (blood in urine) is a classic clinical sign of over-dosage or a high INR. **3. NEET-PG High-Yield Pearls:** * **Bridge Therapy:** Warfarin has a delayed onset (36–72 hours) because it doesn't affect factors already in circulation [3]. Heparin is often started simultaneously to provide immediate anticoagulation. * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes **Fetal Warfarin Syndrome**) [2]; Heparin is the drug of choice as it does not cross the placenta. * **Antidote:** The specific antidote for Warfarin overdose is **Vitamin K1 (Phytonadione)** [2]. For immediate reversal, **Fresh Frozen Plasma (FFP)** or Prothrombin Complex Concentrate (PCC) is used. * **Monitoring:** Warfarin therapy is monitored using **PT/INR**, whereas Heparin is monitored using **aPTT**.

Question 107: Which agents or drugs help in the rapid coagulation of blood?

A. Astringents
B. Styptics
C. Haemostatics
D. All of the above (Correct Answer)

Explanation: **Explanation:** The correct answer is **D. All of the above**, as all three classes of agents contribute to the cessation of bleeding (hemostasis) through different mechanisms, ranging from local protein precipitation to systemic coagulation cascade activation. 1. **Astringents:** These are locally acting pharmacodynamic agents (e.g., Tannic acid, Alum, Zinc sulfate) that cause the **precipitation of surface proteins**. When applied to a bleeding site, they form a mechanical plug of precipitated proteins that seals off small capillaries and arterioles, thereby aiding in rapid local coagulation. 2. **Styptics:** This is a specific clinical term for **local hemostatics**. They are concentrated forms of astringents or specific agents (e.g., Ferric chloride, Silver nitrate, Adrenaline-soaked swabs) applied topically to arrest bleeding from small wounds or mucous membranes by inducing immediate vasoconstriction and protein coagulation. 3. **Haemostatics:** This is a broad category that includes both local and **systemic agents** used to arrest hemorrhage. Systemic haemostatics (e.g., Vitamin K, Ethamsylate, Tranexamic acid, Fibrinogen) work by promoting the coagulation cascade or inhibiting fibrinolysis, ensuring rapid blood clot stabilization. **Why "All of the above" is correct:** While their mechanisms differ (local vs. systemic; physical vs. biochemical), all three groups share the common therapeutic goal of accelerating blood coagulation and achieving hemostasis. **High-Yield Clinical Pearls for NEET-PG:** * **Tranexamic Acid:** An antifibrinolytic that competitively inhibits the activation of plasminogen to plasmin. * **Ethamsylate:** Corrects abnormal platelet adhesion and strengthens capillary wall resistance. * **Vitamin K:** Essential for the synthesis of clotting factors **II, VII, IX, and X** in the liver. * **Local Hemostatics:** Often used in dental procedures or minor surgical oozing (e.g., Gelfoam, Oxidized cellulose).

Question 108: Danaparoid is:

A. An Xa analog
B. An oral Xa inhibitor
C. A parenteral Xa inhibitor (Correct Answer)
D. An oral direct thrombin inhibitor

Explanation: **Explanation:** **Danaparoid** is a heparinoid mixture consisting of heparan sulfate, dermatan sulfate, and chondroitin sulfate. Its primary mechanism of action is the **indirect inhibition of Factor Xa** by enhancing the activity of antithrombin III. 1. **Why Option C is Correct:** Danaparoid is administered via **parenteral routes** (subcutaneous or intravenous). It has a high anti-Xa to anti-IIa ratio (approximately 20:1), making it a potent and selective Factor Xa inhibitor. Its clinical hallmark is its lack of cross-reactivity with heparin-induced antibodies, making it a first-line alternative for patients with **Heparin-Induced Thrombocytopenia (HIT)**. 2. **Why Other Options are Incorrect:** * **Option A:** It is not an "analog" of Factor Xa; it is an inhibitor of its activity. * **Option B:** Oral Xa inhibitors (Rivaroxaban, Apixaban, Edoxaban) belong to the DOAC (Direct Oral Anticoagulant) class and act directly on Xa without requiring antithrombin. * **Option D:** Oral direct thrombin inhibitors (e.g., Dabigatran) act on Factor IIa. Danaparoid has minimal effect on thrombin (IIa). **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Danaparoid is frequently tested as a safe alternative for anticoagulation in **HIT** and in pregnant patients who develop HIT (as it does not cross the placenta). * **Monitoring:** Unlike Heparin, it does not significantly prolong aPTT. Monitoring is done using **anti-Xa assays** if necessary. * **Half-life:** It has a long half-life (~24 hours), which is significantly longer than LMWH.

Question 109: Urgent reversal of warfarin-induced bleeding can be achieved by the administration of which of the following?

A. Cryoprecipitate
B. Platelet concentrates
C. Fresh frozen plasma (Correct Answer)
D. Packed red blood cells

Explanation: **Explanation:** Warfarin exerts its anticoagulant effect by inhibiting the enzyme **Vitamin K Epoxide Reductase (VKOR)**, which prevents the gamma-carboxylation (activation) of clotting factors **II, VII, IX, and X**. In cases of life-threatening bleeding or urgent surgery, the goal is to immediately replace these functional clotting factors. **Why Fresh Frozen Plasma (FFP) is correct:** FFP contains all the coagulation factors in their active forms. It is the standard treatment for the rapid reversal of warfarin because it provides an immediate source of the Vitamin K-dependent factors that the patient’s liver cannot currently produce. While **Prothrombin Complex Concentrate (PCC)** is technically the first-line treatment in modern guidelines due to faster action and lower volume, FFP remains the classic and correct choice among the provided options. **Why the other options are incorrect:** * **A. Cryoprecipitate:** This is rich in Factor VIII, von Willebrand factor, and Fibrinogen. It does not contain sufficient amounts of the Vitamin K-dependent factors (II, VII, IX, X) required for warfarin reversal. * **B. Platelet concentrates:** Warfarin affects the coagulation cascade (humoral immunity), not platelet count or function. * **D. Packed red blood cells:** These are used to restore oxygen-carrying capacity in anemia or hemorrhage but do not contain clotting factors. **High-Yield NEET-PG Pearls:** * **Antidote for Warfarin:** Vitamin K (Phytonadione) is used for non-urgent reversal, but it takes 6–24 hours to work as it requires new protein synthesis. * **Immediate Reversal:** PCC (Prothrombin Complex Concentrate) > FFP. * **Monitoring:** Warfarin is monitored using **PT/INR** (Extrinsic pathway). * **Teratogenicity:** Warfarin is contraindicated in pregnancy (causes Fetal Warfarin Syndrome); Heparin is the preferred anticoagulant for pregnant women.

Question 110: What is the dose of vitamin K in cases of serious bleeding?

A. 2.5 mg
B. 5 mg
C. 10 mg (Correct Answer)
D. 20 mg

Explanation: **Explanation:** The management of Warfarin-induced bleeding is a high-yield topic for NEET-PG. The correct dose of Vitamin K (Phytonadione) depends on the severity of the bleeding and the International Normalized Ratio (INR) levels. **Why 10 mg is correct:** In cases of **serious or life-threatening bleeding** (regardless of the INR), the standard protocol involves the rapid reversal of anticoagulation. The recommended dose is **10 mg of Vitamin K1**, administered via **slow intravenous infusion**. Because Vitamin K takes 6–12 hours to synthesize new clotting factors, it must be supplemented with immediate replacement factors like **Prothrombin Complex Concentrate (PCC)** or Fresh Frozen Plasma (FFP) in emergency scenarios. **Analysis of incorrect options:** * **A (2.5 mg) & B (5 mg):** These lower doses are typically used for **asymptomatic patients** with significantly elevated INR (usually >9) but no active bleeding. In these cases, oral administration is preferred over IV. * **D (20 mg):** Doses exceeding 10 mg are generally avoided. Higher doses do not provide faster reversal and can lead to "Warfarin resistance" for several days, making it difficult to re-anticoagulate the patient once the bleeding is controlled. **High-Yield Clinical Pearls for NEET-PG:** * **Route of Administration:** In serious bleeding, IV is preferred. However, IV Vitamin K carries a small risk of **anaphylactoid reactions**; hence, it must be infused slowly. * **Oral vs. SC:** Oral Vitamin K is highly effective for non-emergency reversal. **Subcutaneous (SC) administration is avoided** because it is unpredictable and less effective than oral or IV routes. * **Mechanism:** Vitamin K acts as a cofactor for the enzyme **gamma-glutamyl carboxylase**, which activates Factors II, VII, IX, and X.

Practice by Chapter

Hematopoietic Growth Factors

Practice Questions

Iron Preparations and Management of Iron Deficiency

Practice Questions

Vitamin B12 and Folic Acid

Practice Questions

Anticoagulants: Heparins and Direct Inhibitors

Practice Questions

Oral Anticoagulants

Practice Questions

Antiplatelet Drugs

Practice Questions

Thrombolytic Agents

Practice Questions

Hemostatic Drugs

Practice Questions

Plasma Expanders

Practice Questions

Blood Transfusion and Alternatives

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free